Granulocyte-colony stimulating factor facilitates the restoration of resistance to opportunistic fungi in leukopenic mice

REFERENCES

• Bolanos B., Mitchell T.G. Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum. Journal of Leukocyte Biology 1989; 46: 521–528
   PubMed Web of Science ®Google Scholar
• Bulmer G.S., Sans M.D. Cryptococcus neoformans. III. Inhibition of phagocytosis. Journal of Bacteriology 1968; 95: 5–8
   PubMed Web of Science ®Google Scholar
• Cohen A.M., Hines D.K., Korach E.S., Ratzkin B.J. In vivo activation of neutrophil function in hamsters by recombinant human granulocyte colony-stimulating factor. Infection and Immunity 1988; 56: 2861–2865
   PubMed Web of Science ®Google Scholar
• Cohen M.S., Isturiz R.E., Malech H.L., Root R.K., Wilfert C.M., Gutman L., Buckley R.P.H. Fungal infection in chronic granulomatous disease: the importance of the phagocyte in defense against fungi. American Journal of Medicine 1981; 71: 59–66
   PubMed Web of Science ®Google Scholar
• Diamond R.D., Krzesicki R.K. Mechanism of attachment of neutrophils to Candida albicans pseudohyphae in the absence of serum and of subsequent damage to pseudohyphase by microbicidal processes of neutrophils in vitro. Journal of Clinical Investigation 1978; 61: 360–369
   PubMed Web of Science ®Google Scholar
• Diamond R.D., Krezesicki R.K., Epstein B., Jao W. Damage to hyphal forms of fungi by human leukocytes in vitro: a possible host defense mechanism in aspergillosis and mucormycosis. American Journal of Pathology 1978; 91: 313–324
   PubMed Web of Science ®Google Scholar
• Gold J.W.M. Opportunistic fungal infections in patients with neoplastic disease. American Journal of Medicine 1984; 76: 458–463
   PubMed Web of Science ®Google Scholar
• Hasegawa T., Yamamoto Y., Widen R., Yamaguchi H., Friedman H., Klein T.W. Recombinant G- and GM-CSF induce a selective antimicrobial activity in human peripheral blood neutrophils. Lymphokine Research 1990; 9: 616–616
   Google Scholar
• Hattori K., Shimizu K., Takahashi M., Tamura M., Oheda M., Ohsawa N., Ono M. Quantitative in vivo assay of human granulocyte colony-stimulating factor using cyclophosphamide-induced neutropenic mice. Blood 1990; 75: 1228–1233
   PubMed Web of Science ®Google Scholar
• Kozel T.R., Pfrommer G.S.T., Guerlain A.S., Highison B.A., Hizhison G.J. Role of capsule in phagocytosis of Cryptococcus neoformans. Reviews of Infectious Diseases 1988; 10: 5436–5439
   Google Scholar
• Levitz S.M. Aspergillosis. Infectious Disease Clinics of North America 1989; 3: 1–18
   PubMedGoogle Scholar
• Matsumoto M., Matsubara S., Matsuno T., Ono M., Yokota T. Protective effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) against various microbial infections in neutropenic mice. Microbiology and Immunogy 1990; 34: 765–773
   PubMed Web of Science ®Google Scholar
• Matsumoto M., Matsubara S., Matsuno T., Tamura M., Hattori K., Nomura H., Ono M., Yokota T. Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice. Infection and Immunity 1987; 55: 2715–2720
   PubMed Web of Science ®Google Scholar
• Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood 1986; 67: 257–267
   PubMed Web of Science ®Google Scholar
• Meyer R.D., Young L.S., Armstrong D., Yu B. Aspergillosis complicating neoplastic disease. American Journal of Medicine 1973; 54: 6–15
   PubMed Web of Science ®Google Scholar
• Miller G.P.G. The immunology of cryptococcal disease. Seminars in Respiratory Infections 1986; 1: 45–52
   PubMedGoogle Scholar
• Murphy J.W. Cryptococcosis. Immunology of the Fungal Diseases, R.A. Cox. CRC Press, Boca Raton, FL 1989; 93–138, In
   Google Scholar
• Nicola N.A., Vadas M. Hematopoietic colony-stimulating factors. Immunology Today 1984; 5: 76–80
   PubMedGoogle Scholar
• Shinomiya N., Tsuru S., Katsura Y., Kayashima S., Nomoto K. Enhanced resistance against Listeria monocytogenes achieved by pretreatment with granulocyte colony-stimulating factor. Infection and Immunity 1991; 59: 4740–4743
   PubMed Web of Science ®Google Scholar
• Small J.M., Mitchell T.G. Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A. Infection and Immunity 1989; 57: 3751–3756
   PubMed Web of Science ®Google Scholar
• Souza L.M., Boone T.C., Gabrilove J., Lai P.H., Zesbo K.M., Murdock D.C., Chazin V.R., Bruszewsk J., Lu H., Chen K.K., Barendt J., Platzer E., Moore M.A.S., Mertelsman R., Welte K. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 1986; 232: 61–65
   PubMed Web of Science ®Google Scholar
• Tamura M., Hattori K., Nomura H., Oheda M., Kubota N., Imazeki I., Ono M., Ufyama Y., Nagata S., Shirafuji N., Asano S. Induction of neutrophilic granulocytosis in mice by administration of purified human native granulocyte colony-stimulating factor (G-CSF). Biochemical and Biophysical Research Communications 1987; 142: 454–460
   PubMed Web of Science ®Google Scholar
• Warnock D.W. Immunological and other defects predisposing to fungal infections in the compromised host. Fungal Infection in the Compromised Patient, D.W. Warnock, M.D. Richardson. John Wiley and Sons, Chichester 1982; 29–47, In
   Google Scholar
• Welte K., Bonilla M.A., Gillion A.P., Boone T.C., Potter G.K., Gabrilove J.G., Moore M.A.S., O'Reiely R.J., Souza L.M. Recombinant human granulocyte colony-stimulating factor: effects on hematopoiesis in normal and cyclophosphamide-treated primates. Journal of Experimental Medicine 1987; 165: 941–948
   PubMed Web of Science ®Google Scholar
• Young R.C., Bennett J.E., Vogel C.L., Carbone P.P., DeVita V.T. Aspergillosis: the spectrum of the disease in 98 patients. Medicine 1970; 49: 147–173
   PubMed Web of Science ®Google Scholar